Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


At least 47 dead in eastern Indonesia after magnitude 7.7 quake
Kuwait, Bahrain strongly condemn Iranian attack on ADNOC vessels
Yemen's Mocha port halts operations after Houthi attacks, port director says
Morocco arrests 111 migrants headed for Spain's Ceuta in security crackdown
